RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재 SCI SCIE SCOPUS

      Persistence with Antihypertensive Medications in Uncomplicated Treatment-Naïve Patients: Effects of Initial Therapeutic Classes

      한글로보기

      https://www.riss.kr/link?id=A104770215

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract)

      We aimed to assess one-year persistence with antihypertensive therapy (AHT) among newly treated uncomplicated hypertensive patients in Korea and to evaluate the effect of initial therapeutic classes on persistence. We retrospectively analyzed a random sample of 20% of newly treated uncomplicated hypertensive patients (n = 45,787) in 2012 from the National Health Insurance claims database. This group was classified into six cohorts based on initial AHT class. We then measured treatment persistence, allowing a prescription gap of 60 days. Adherence to AHT was assessed with the medication possession ratio. Calcium channel blockers (CCB, 43.7%) and angiotensin receptor blockers (ARB, 40.3%) were most commonly prescribed as initial monotherapy. Overall, 62.1% and 42.0% were persistent with any AHT and initial class at one year, respectively, and 64.2% were adherent to antihypertensive treatment. Compared with ARBs, the risk of AHT discontinuation was significantly increased with initial use of thiazide diuretics (hazard ratio [HR], 3.16; 95% confidence interval [CI] 2.96-3.74) and beta blockers (HR, 1.86; CI, 1.77-1.95) and was minimally increased with CCBs (HR, 1.12; CI, 1.08-1.15). In conclusion, persistence and adherence to AHT are suboptimal, but the differences are meaningful in persistence and adherence between initial AHT classes.
      번역하기

      We aimed to assess one-year persistence with antihypertensive therapy (AHT) among newly treated uncomplicated hypertensive patients in Korea and to evaluate the effect of initial therapeutic classes on persistence. We retrospectively analyzed a random...

      We aimed to assess one-year persistence with antihypertensive therapy (AHT) among newly treated uncomplicated hypertensive patients in Korea and to evaluate the effect of initial therapeutic classes on persistence. We retrospectively analyzed a random sample of 20% of newly treated uncomplicated hypertensive patients (n = 45,787) in 2012 from the National Health Insurance claims database. This group was classified into six cohorts based on initial AHT class. We then measured treatment persistence, allowing a prescription gap of 60 days. Adherence to AHT was assessed with the medication possession ratio. Calcium channel blockers (CCB, 43.7%) and angiotensin receptor blockers (ARB, 40.3%) were most commonly prescribed as initial monotherapy. Overall, 62.1% and 42.0% were persistent with any AHT and initial class at one year, respectively, and 64.2% were adherent to antihypertensive treatment. Compared with ARBs, the risk of AHT discontinuation was significantly increased with initial use of thiazide diuretics (hazard ratio [HR], 3.16; 95% confidence interval [CI] 2.96-3.74) and beta blockers (HR, 1.86; CI, 1.77-1.95) and was minimally increased with CCBs (HR, 1.12; CI, 1.08-1.15). In conclusion, persistence and adherence to AHT are suboptimal, but the differences are meaningful in persistence and adherence between initial AHT classes.

      더보기

      참고문헌 (Reference)

      1 Larochelle P, "β-Blockers in hypertension: studies and meta-analyses over the years" 30 : S16-S22, 2014

      2 Han E, "The impact of medication adherence on health outcomes for chronic metabolic diseases: a retrospective cohort study" 10 : e87-e98, 2014

      3 McDowell SE, "Systematic review and metaanalysis of ethnic differences in risks of adverse reactions to drugs used in cardiovascular medicine" 332 : 1177-1181, 2006

      4 Matchar DB, "Systematic review : comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers for treating essential hypertension" 148 : 16-29, 2008

      5 Bakris G, "Review of blood pressure control rates and outcomes" 8 : 127-141, 2014

      6 Mathes J, "Relation of the first hypertension-associated event with medication, compliance and persistence in naive hypertensive patients after initiating monotherapy" 48 : 173-183, 2010

      7 Lemstra M, "Proportion and risk indicators of nonadherence to antihypertensive therapy : a meta-analysis" 8 : 211-218, 2014

      8 Jo I, "Prevalence, awareness, treatment, control and risk factors of hypertension in Korea: the Ansan study" 19 : 1523-1532, 2001

      9 Elliott WJ, "Persistence, adherence, and risk of discontinuation associated with commonly prescribed antihypertensive drug monotherapies" 20 : 72-80, 2007

      10 Hasford J, "Persistence with antihypertensive treatments : results of a 3-year followup cohort study" 63 : 1055-1061, 2007

      1 Larochelle P, "β-Blockers in hypertension: studies and meta-analyses over the years" 30 : S16-S22, 2014

      2 Han E, "The impact of medication adherence on health outcomes for chronic metabolic diseases: a retrospective cohort study" 10 : e87-e98, 2014

      3 McDowell SE, "Systematic review and metaanalysis of ethnic differences in risks of adverse reactions to drugs used in cardiovascular medicine" 332 : 1177-1181, 2006

      4 Matchar DB, "Systematic review : comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers for treating essential hypertension" 148 : 16-29, 2008

      5 Bakris G, "Review of blood pressure control rates and outcomes" 8 : 127-141, 2014

      6 Mathes J, "Relation of the first hypertension-associated event with medication, compliance and persistence in naive hypertensive patients after initiating monotherapy" 48 : 173-183, 2010

      7 Lemstra M, "Proportion and risk indicators of nonadherence to antihypertensive therapy : a meta-analysis" 8 : 211-218, 2014

      8 Jo I, "Prevalence, awareness, treatment, control and risk factors of hypertension in Korea: the Ansan study" 19 : 1523-1532, 2001

      9 Elliott WJ, "Persistence, adherence, and risk of discontinuation associated with commonly prescribed antihypertensive drug monotherapies" 20 : 72-80, 2007

      10 Hasford J, "Persistence with antihypertensive treatments : results of a 3-year followup cohort study" 63 : 1055-1061, 2007

      11 Grimmsmann T, "Persistence of antihypertensive drug use in German primary care : a follow-up study based on pharmacy claims data" 70 : 295-301, 2014

      12 Trimarco V, "Persistence and adherence to antihypertensive treatment in relation to initial prescription : diuretics versus other classes of antihypertensive drugs" 30 : 1225-1232, 2012

      13 Mazzaglia G, "Patterns of persistence with antihypertensive medications in newly diagnosed hypertensive patients in Italy : a retrospective cohort study in primary care" 23 : 2093-2100, 2005

      14 Cramer JA, "Medication compliance and persistence : terminology and definitions" 11 : 44-47, 2008

      15 Klootwyk J, "Medication adherence and persistence in hypertension management" 18 : 351-358, 2011

      16 Law M, "Lowering blood pressure to prevent myocardial infarction and stroke : a new preventive strategy" 7 : 1-94, 2003

      17 Elliott WJ, "Improving outcomes in hypertensive patients : focus on adherence and persistence with antihypertensive therapy" 11 : 376-382, 2009

      18 Sung SK, "First-year treatment adherence among outpatients initiating antihypertensive medication in Korea : results of a retrospective claims review" 31 : 1309-1320, 2009

      19 Mancia G, "Factors involved in the discontinuation of antihypertensive drug therapy : an analysis from real life data" 32 : 1708-1715, 2014

      20 Patel BV, "Effects of initial antihypertensive drug class on patient persistence and compliance in a usual-care setting in the United States" 9 : 692-700, 2007

      21 Jones JK, "Discontinuation of and changes in treatment after start of new courses of antihypertensive drugs : a study of a United Kingdom population" 311 : 293-295, 1995

      22 Kim HK, "Differences in adherence to antihypertensive medication regimens according to psychiatric diagnosis : results of a Korean population-based study" 72 : 80-87, 2010

      23 Selmer R, "Choice of initial antihypertensive drugs and persistence of drug use--a 4-year follow-up of 78,453incident users" 68 : 1435-1442, 2012

      24 Guertin JR, "Canadian Cardiovascular Outcomes Research Team. The potential economic impact of restricted access to angiotensin-receptor blockers" 183 : E180-E186, 2011

      25 Liu PH, "Antihypertensive medication prescription patterns and time trends for newly-diagnosed uncomplicated hypertension patients in Taiwan" 8 : 133-, 2008

      26 Tu K, "Antihypertensive drug prescribing and persistence among new elderly users:implications for persistence improvement interventions" 30 : 647-652, 2014

      27 Friedman O, "Antihypertensive drug persistence and compliance among newly treated elderly hypertensives in ontario" 123 : 173-181, 2010

      28 Mazzaglia G, "Adherence to antihypertensive medications and cardiovascular morbidity among newly diagnosed hypertensive patients" 120 : 1598-1605, 2009

      29 Hill MN, "Adherence and persistence with taking medication to control high blood pressure" 5 : 56-63, 2011

      30 Charlson ME, "A new method of classifying prognostic comorbidity in longitudinal studies : development and validation" 40 : 373-383, 1987

      31 Faria C, "A narrative review of clinical inertia : focus on hypertension" 3 : 267-276, 2009

      32 van Wijk BL, "A cross-national study of the persistence of antihypertensive medication use in the elderly" 26 : 145-153, 2008

      더보기

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      2023 평가예정 해외DB학술지평가 신청대상 (해외등재 학술지 평가)
      2020-01-01 평가 등재학술지 유지 (해외등재 학술지 평가) KCI등재
      2011-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2009-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2005-01-01 평가 SCI 등재 (등재유지) KCI등재
      2002-01-01 평가 등재학술지 선정 (등재후보2차) KCI등재
      1999-07-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 1.48 0.37 1.06
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      0.85 0.75 0.691 0.11
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼